Volume 74, Issue 10-11

Search all Journal of Biomolecular NMR articles

November 2020

Special Issue: NMR in Pharmaceutical Discovery and Development

Issue Editors:

Raymond S. Norton,
Wolfgang Jahnke

16 articles in this issue

NMR in pharmaceutical discovery and development
Raymond S. Norton
Wolfgang Jahnke
Communication 04 September 2020 Pages: 473 - 476
Correction to: NMR in pharmaceutical discovery and development
Raymond S. Norton
Wolfgang Jahnke
Correction 13 November 2020 Pages: 477 - 477
The role of NMR in leveraging dynamics and entropy in drug design
Abhinav Dubey
Koh Takeuchi
Haribabu Arthanari
Perspective 27 July 2020 Pages: 479 - 498
Correction to: The role of NMR in leveraging dynamics and entropy in drug design
Abhinav Dubey
Koh Takeuchi
Haribabu Arthanari
Correction 20 September 2020 Pages: 499 - 500
Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery
Hiroyuki Hanzawa
Takashi Shimada
Hideo Takahashi
Perspective 18 April 2020 Pages: 501 - 508
NMR spectroscopy: the swiss army knife of drug discovery
Reto Horst
Kathleen A. Farley
Jane M. Withka
Article 02 July 2020 Pages: 509 - 519
NMR in target driven drug discovery: why not?
Sébastien Keiffer
Marta G. Carneiro
Gregg Siegal
Perspective Open access 08 September 2020 Pages: 521 - 529
NMR in integrated biophysical drug discovery for RAS: past, present, and future
Christopher B. Marshall
Fenneke KleinJan
Mitsuhiko Ikura
Perspective 17 August 2020 Pages: 531 - 554
NMR quality control of fragment libraries for screening
Sridhar Sreeramulu
Christian Richter
Harald Schwalbe
Article Open access 12 June 2020 Pages: 555 - 563
CcpNmr AnalysisScreen, a new software programme with dedicated automated analysis tools for fragment-based drug discovery by NMR
Luca G. Mureddu
Timothy J. Ragan
Geerten W. Vuister
Article Open access 07 July 2020 Pages: 565 - 577
Efficient affinity ranking of fluorinated ligands by ¹⁹F NMR: CSAR and FastCSAR
Simon H. Rüdisser
Nils Goldberg
Alvar D. Gossert
Article 16 June 2020 Pages: 579 - 594
NMR fragment screening reveals a novel small molecule binding site near the catalytic surface of the disulfide–dithiol oxidoreductase enzyme DsbA from Burkholderia pseudomallei
Stefan Nebl
Wesam S. Alwan
Martin J. Scanlon
Article 06 August 2020 Pages: 595 - 611
Fluorine NMR functional screening: from purified enzymes to human intact living cells
Claudio Dalvit
Marina Veronesi
Anna Vulpetti
Article 28 April 2020 Pages: 613 - 631
Protein—ligand structure determination with the NMR molecular replacement tool, NMR²
Julien Orts
Roland Riek
Article 03 July 2020 Pages: 633 - 642
Principal component analysis for automated classification of 2D spectra and interferograms of protein therapeutics: influence of noise, reconstruction details, and data preparation
Robert G. Brinson
K. Wade Elliott
Frank Delaglio
Article 22 July 2020 Pages: 643 - 656
Protein NMR of biologicals: analytical support for development and marketed products
Fabio Casagrande
Klara Dégardin
Alfred Ross
Article 29 April 2020 Pages: 657 - 671

Volume 74, Issue 10-11

NMR in pharmaceutical discovery and development

Correction to: NMR in pharmaceutical discovery and development

The role of NMR in leveraging dynamics and entropy in drug design

Correction to: The role of NMR in leveraging dynamics and entropy in drug design

Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery

NMR spectroscopy: the swiss army knife of drug discovery

NMR in target driven drug discovery: why not?

NMR in integrated biophysical drug discovery for RAS: past, present, and future

NMR quality control of fragment libraries for screening

CcpNmr AnalysisScreen, a new software programme with dedicated automated analysis tools for fragment-based drug discovery by NMR

Efficient affinity ranking of fluorinated ligands by ¹⁹F NMR: CSAR and FastCSAR

NMR fragment screening reveals a novel small molecule binding site near the catalytic surface of the disulfide–dithiol oxidoreductase enzyme DsbA from Burkholderia pseudomallei

Fluorine NMR functional screening: from purified enzymes to human intact living cells

Protein—ligand structure determination with the NMR molecular replacement tool, NMR²

Principal component analysis for automated classification of 2D spectra and interferograms of protein therapeutics: influence of noise, reconstruction details, and data preparation

Protein NMR of biologicals: analytical support for development and marketed products

Navigation